Literature DB >> 24262753

Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization.

Josef Ehling1, Benjamin Theek2, Felix Gremse2, Sarah Baetke2, Diana Möckel2, Juliana Maynard3, Sally-Ann Ricketts3, Holger Grüll4, Michal Neeman5, Ruth Knuechel6, Wiltrud Lederle2, Fabian Kiessling7, Twan Lammers8.   

Abstract

Angiogenesis is a hallmark of cancer, and its noninvasive visualization and quantification are key factors for facilitating translational anticancer research. Using four tumor models characterized by different degrees of aggressiveness and angiogenesis, we show that the combination of functional in vivo and anatomical ex vivo X-ray micro-computed tomography (μCT) allows highly accurate quantification of relative blood volume (rBV) and highly detailed three-dimensional analysis of the vascular network in tumors. Depending on the tumor model, rBV values determined using in vivo μCT ranged from 2.6% to 6.0%, and corresponds well with the values assessed using IHC. Using ultra-high-resolution ex vivo μCT, blood vessels as small as 3.4 μm and vessel branches up to the seventh order could be visualized, enabling a highly detailed and quantitative analysis of the three-dimensional micromorphology of tumor vessels. Microvascular parameters such as vessel size and vessel branching correlated very well with tumor aggressiveness and angiogenesis. In rapidly growing and highly angiogenic A431 tumors, the majority of vessels were small and branched only once or twice, whereas in slowly growing A549 tumors, the vessels were much larger and branched four to seven times. Thus, we consider that combining highly accurate functional with highly detailed anatomical μCT is a useful tool for facilitating high-throughput, quantitative, and translational (anti-) angiogenesis and antiangiogenesis research.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24262753      PMCID: PMC3920056          DOI: 10.1016/j.ajpath.2013.10.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.

Authors:  Fabian Eisa; Robert Brauweiler; Martin Hupfer; Tristan Nowak; Laura Lotz; Inge Hoffmann; David Wachter; Ralf Dittrich; Matthias W Beckmann; Gregor Jost; Hubertus Pietsch; Willi A Kalender
Journal:  Eur Radiol       Date:  2011-11-10       Impact factor: 5.315

2.  Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.

Authors:  Dimitra Bourboulia; Sandra Jensen-Taubman; Matthew R Rittler; Hui Ying Han; Tania Chatterjee; Beiyang Wei; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

3.  Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).

Authors:  Tao Jiang; Avinash Kambadakone; Naveen M Kulkarni; Andrew X Zhu; Dushyant V Sahani
Journal:  Invest Radiol       Date:  2012-01       Impact factor: 6.016

4.  Concurrent MR blood volume and vessel size estimation in tumors by robust and simultaneous ΔR2 and ΔR2* quantification.

Authors:  Stefanie Remmele; Janine Ring; Julien Sénégas; Walter Heindel; Rolf M Mesters; Christoph Bremer; Thorsten Persigehl
Journal:  Magn Reson Med       Date:  2011-02-08       Impact factor: 4.668

Review 5.  CT imaging of angiogenesis.

Authors:  T-Y Lee; T G Purdie; E Stewart
Journal:  Q J Nucl Med       Date:  2003-09

6.  Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer.

Authors:  Rajkumar Savai; Alexander Claus Langheinrich; Ralph Theo Schermuly; Soni Savai Pullamsetti; Rio Dumitrascu; Horst Traupe; Wigbert Stephan Rau; Werner Seeger; Friedrich Grimminger; Gamal Andre Banat
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging.

Authors:  Benjamin J Vakoc; Ryan M Lanning; James A Tyrrell; Timothy P Padera; Lisa A Bartlett; Triantafyllos Stylianopoulos; Lance L Munn; Guillermo J Tearney; Dai Fukumura; Rakesh K Jain; Brett E Bouma
Journal:  Nat Med       Date:  2009-09-13       Impact factor: 53.440

9.  Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.

Authors:  Joo Ho Tai; Jean Tessier; Anderson J Ryan; Lisa Hoffman; Xiaogang Chen; Ting-Yim Lee
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

10.  Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography.

Authors:  K A Miles; T-Y Lee; V Goh; E Klotz; C Cuenod; S Bisdas; A M Groves; M P Hayball; R Alonzi; T Brunner
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

View more
  61 in total

1.  Quantification of Morphological Features in Non-Contrast-Enhanced Ultrasound Microvasculature Imaging.

Authors:  Siavash Ghavami; Mahdi Bayat; Mostafa Fatemi; Azra Alizad
Journal:  IEEE Access       Date:  2020-01-21       Impact factor: 3.367

Review 2.  Perspectives: MRI of angiogenesis.

Authors:  Michal Neeman
Journal:  J Magn Reson       Date:  2018-04-12       Impact factor: 2.229

3.  The use of nano-computed tomography to enhance musculoskeletal research.

Authors:  Basma M Khoury; Erin M R Bigelow; Lauren M Smith; Stephen H Schlecht; Erica L Scheller; Nelly Andarawis-Puri; Karl J Jepsen
Journal:  Connect Tissue Res       Date:  2015-02-03       Impact factor: 3.417

4.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

5.  Vascular Casting of Adult and Early Postnatal Mouse Lungs for Micro-CT Imaging.

Authors:  Russell H Knutsen; Leah M Gober; Joseph R Sukinik; Danielle R Donahue; Elise K Kronquist; Mark D Levin; Sean E McLean; Beth A Kozel
Journal:  J Vis Exp       Date:  2020-06-20       Impact factor: 1.355

Review 6.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

7.  Optimization of Contrast-to-Tissue Ratio Through Pulse Windowing in Dual-Frequency "Acoustic Angiography" Imaging.

Authors:  Brooks D Lindsey; Sarah E Shelton; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-03-25       Impact factor: 2.998

8.  A method to quantify and visualize femoral head intraosseous arteries by micro-CT.

Authors:  Xing Qiu; Xiaotian Shi; Jun Ouyang; Dachuan Xu; Dewei Zhao
Journal:  J Anat       Date:  2016-04-14       Impact factor: 2.610

9.  Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice.

Authors:  Chichi Xie; Weiwei Wei; Andrea Schenk; Lars Ole Schwen; Sara Zafarnia; Michael Schwier; Felix Gremse; Isabel Jank; Olaf Dirsch; Uta Dahmen
Journal:  J Vis Exp       Date:  2016-09-13       Impact factor: 1.355

10.  Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer.

Authors:  Kayla J Steinberger; Mary A Forget; Andrey A Bobko; Nicole E Mihalik; Marieta Gencheva; Julie M Roda; Sara L Cole; Xiaokui Mo; E Hannah Hoblitzell; Randall Evans; Amy C Gross; Leni Moldovan; Clay B Marsh; Valery V Khramstov; Timothy D Eubank
Journal:  J Immunol       Date:  2020-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.